Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-003921

Chief Executive Officer sold 50,000 shares at $36.80 ($1,840,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Violin Jonathan Chief Executive Officer 2023-02-02 Sale −50,000 $36.80 $1,840,000 430,905 D
Open-market sales · 50,000 sh · avg $36.80 · $1,840,000
Loading xslF345X03/doc4.xml…